|
|
Founded in 1996 by four of the senior partners of Burr, Egan, Deleage & Co., Alta Partners currently manages eight venture fund programs aggregating approximately $2.0 billion in committed capital. Initially an early stage firm, Alta entered later stage investing with the formation of Alta BioPharma I, a fund focused on growth stage private companies and young public companies in the life sciences sector. ACP IV marked Alta's shift towards a singular focus on life sciences investing. Alta Partners VIII, the firm's most recent fund, is the first stage-independent life sciences fund for Alta. AP VIII will target companies across the continuum, from company formation to later-stage companies, both private and public. Since its inception, Alta has invested over $1.4 billion in more than 145 life sciences companies. The team has raised $2.6 billion across 11 funds.
|
